Category Archives: Asbestos

DNA

ToxicoGenomica at the DRI Toxic Torts and Environmental Law Seminar 2025: Tackling the Impediments to Obtaining and Using Genetic Testing in Toxic Tort Cases

| May 15, 2025

Dr. Len Van Zyl of ToxicoGenomica recently joined a distinguished panel at the 2025 Toxic Torts and Environmental Law Seminar, held from March 26-28 in Atlanta. The panel, titled Offense is the Best Defense: Tackling the Impediments to Obtaining and Using Genetic Testing in Toxic Tort Cases, explored the latest scientific studies on genetic causation […]

Learn More
DNA

Perrin Conferences Presents: 2023 Brings Multiple Waves of Additional Studies Regarding Mesotheliomas and Other Cancers Caused Solely by Genomic Factors

| June 1, 2023

Join us for this complimentary CLE webinar on Tuesday, July 18, 2023 from 2:00-3:30 pm ET. This webinar will focus on the latest publications, scientific studies, and statistics regarding genomics role in cancers. It will also cover predictive software and other tools for understanding the impact of germline mutations on disease development and progression. There […]

Learn More

Key Developments in the Use of Genomics in Mesothelioma Cases: Causal Role of BAP1 Null (Loss of Function) Mutations in Mesothelioma and Key Legal Findings

| December 19, 2022

ToxicoGenomica recently presented a webinar organized by Perrin Conferences and the slides are now available for download. The title of the session was Key Developments: Genomics in Mesothelioma Cases. The webinar focused on the latest cases, the most recent science and publications, and the evolving applications and cost of deployment of the science of genomics […]

Learn More

ToxicoGenomica at Perrin Conference 2022: Cancer Causation in Toxic Tort Cases

| March 22, 2022

The recent Perrin Conference on Cutting-Edge Issues in Asbestos Litigation (March 7 and 8, 2022) included a panel on the very cutting edge topic of using genetic sequencing data in litigation involving mesotheliomas and other cancers. Our Kirk Hartley presented and covered a wide range of topics at some of the many intersections between science […]

Learn More

Upcoming Perrin Conference on Cutting-Edge Issues in Asbestos Litigation: Beverly Hills, CA

| March 3, 2022

The use of genomic analysis to evaluate mesothelioma causation is a topic that will be covered at the upcoming Perrin Conference on Cutting-Edge Issues in Asbestos Litigation. As part of a panel, ToxicoGenomica’s Kirk Hartley will discuss several topics at the intersections between genomic science and law. One portion of his talk will focus on […]

Learn More

Case-Specific Results in Benzene (Blood Cancer) and Mesothelioma Cases [Slides for Download]

| June 3, 2021

At our recent conference Genomic Analysis in Tort Cases, Kirk Hartley, Esq. chaired the first panel addressing the use of genomics in product liability and/or premises cases involving exposures to toxicants, including asbestos, benzene and radiation. Individual panelists provided summaries of cases they worked on involving genomics. Specifically, Kirk Hartley discussed the results from genetic […]

Learn More

Webinar – Legal and Ethical Challenges in Mesothelioma Cases Involving Young People

| September 1, 2020

For first of its kind new data related to the growing number of lawsuits involving young people with mesothelioma, please join next week’s Perrin webinar: Legal and Ethical Challenges in Young Mesothelioma Cases. One key fact is the cases often involve people who have medical histories that include a range of benign tumors, cysts, cancers and/or […]

Learn More
Scientist looking at DNA

New Data Suggest Over-representation of Young Females in 108 Talc-Exposed Mesothelioma Cases Reported by Drs. Moline and Kradin – A Data Compilation

| April 29, 2020

For talc/asbestos litigation, a notable development in 2020 was the publication of two case series articles involving a total of 108 persons who developed mesothelioma.  The authors concluded that all 108 persons could be characterized as having exposure to asbestos only through cosmetic talcum powder. The authors include Dr.  Jacqueline Moline and Dr. Richard Kradin, […]

Learn More

Genomic Evidence Essential to Asbestos and Talc Cases: Dr. Len van Zyl Presents at Perrin National Conference

| September 19, 2019

On September 9, Dr. Len van Zyl of ToxicoGenomica presented at Perrin Conferences’ National Asbestos Litigation Conference at the Fairmont San Francisco Hotel. The conference was greatly attended, and attendees were provided with key information on the trends that are currently driving asbestos litigation and the impact these trends may have on future cases. Dr. […]

Learn More